Carolyn Glass, MD, PhD, has been promoted to the rank of Associate Professor of Pathology. She received her BS in Neuroscience with Departmental Honors from the University of California at Los Angeles (UCLA) in 1997, before earning her MS from Baylor College of Medicine and MD from the University of Texas Medical Branch, Magna Cum Laude in 2007. Glass became one of six residents in the country to matriculate into the first round of 0+5 integrated vascular surgery residencies, training at the University of Rochester Medical Center’s Integrated Vascular Surgery Program from 2007-2011. She subsequently transitioned into a translational research career as a recipient of the NIH National Lung Blood Institute T32 Ruth Kirschstein National Service Research Award and completed a PhD with a concentration in Genomics and Epigenetics in 2014.
Glass completed residency in Anatomic Pathology at the Brigham and Women’s Hospital/Harvard Medical School in 2016 followed by fellowships in Cardiothoracic Pathology also at Brigham and Women’s Hospital and Pulmonary/Transplant Pathology at the University of Texas Southwestern Medical Center. As a thoracic pathologist, she also has a special interest in identifying new epigenetic biomarkers that may predict response or resistance to conventional, targeted and immune therapy using computational techniques. She works closely with the Duke Thoracic Oncology Group and DCI Center for Cancer Immunotherapy.
Glass received the Society of Cardiovascular Pathology (SCVP) Young Investigator’s Award; the William von Liebig Vascular Biology Research Fellowship at the Harvard Institutes of Medicine; the Duke Pathology Salvatore V. Pizzo Faculty Research Mentor Award. She has authored of over 65 publications (including book chapters in the recent W.H.O. Classification Tumors of the Lung, Pleura, Thymus and Heart); and 40 national presentations in cardiovascular disease, thoracic malignancies, surgery and machine learning. She is also an NIH-funded Principal Investigator, most recently garnering a multi-million U54 grant to study cellular senescence in thoracic organs.
In addition to her clinical and research activities, Glass serves as the Chief of Cardiovascular Pathology, Co-Director of the Division of Artificial Intelligence and Computational Pathology, Director of Duke Health Autopsy Service and Associate Program Director of the Duke Pathology Residency Program. She serves on the Executive/National Committees for the SCVP and the College of American Pathology Artificial Intelligence Committee.